#mentalhealth #GedeonRichter #UK #cariprazine #neuropsychiatry #marketingtransfer #Recordati #GedeonRichterUK #RecordatiPharmaceuticals #UKpromotion #MarketingAuthorisation #schizophrenia #adults #centralnervoussystem #CNS #chronicmentalhealthcondition
zurl.co/pROEi
zurl.co/pROEi
Gedeon Richter UK takes over UK rights to cariprazine - PharmaTimes
Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati
pharmatimes.com
February 3, 2026 at 1:09 PM